Journal Mobile Options
Table of Contents
Vol. 8, No. 2, 2000
Issue release date: August 2000
Neuroimmunomodulation 2000;8:70–77
(DOI:10.1159/000026455)

Peripheral Effects of Methionine-Enkephalin on Inflammatory Reactions and Behavior in the Rat

Vujić-Redžić V. · Dimitrijević M. · Stanojević S. · Kovačević-Jovanović V. · Miletić T. · Radulović J.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Methionine-enkephalin (Met-Enk) induces notable alterations in immune and central nervous system functions. The present study was conducted in order to compare peripheral and central effects of Met-Enk on nonspecific immunity, open field behavior and pain perception in the rat. The results showed that 0.2 mg/kg of Met-Enk given intraperitoneally (i.p.) increased concanavalin A (Con-A)-induced paw edema and enhanced basal and phorbol myristate acetate (PMA)-stimulated H2O2 production of peritoneal macrophages. Met-Enk-induced immunopotentiation was antagonized by anti-Met-Enk antibodies (anti-Met-Enk-Ig) and quaternary naltrexone (qNtx). Met-Enk injected i.p. produced an increase of horizontal and vertical locomotor activity in the open field that was reversed by i.p. administration of anti-Met-Enk-Ig and qNtx. The dose of 0.2 mg/kg of Met-Enk applied i.p. did not affect the number of writhes in the test of analgesia. Intracerebroventricular (i.c.v.) injection of Met-Enk, given in a dose that was previously shown to be immunostimulatory, enhanced only basal H2O2 production of peritoneal macrophages, and anti-Met-Enk-Ig antagonized this effect. Besides, i.c.v. treatment with anti-Met-Enk-Ig increased and decreased H2O2 production of peritoneal macrophages under basal and stimulated conditions, respectively. Met-Enk and anti-Met-Enk-Ig injected i.c.v. did not influence activity in the open field and pain sensitivity. Thus, the i.c.v. dose of Met-Enk that was sufficient to modulate immune functions did not influence behavior. It may be concluded that Met-Enk modulated nonspecific immune responses and open field behavior by peripheral mechanisms.

Copyright © 2000 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Janković BD, Marić D: Enkephalins and autoimmunity: Differential effects of methionine-enkephalin on experimental allergic encephalomyelitis in Wistar and Lewis rats. J Neurosci Res 1988;18:88–94.
  2. Janković BD, Radulović J: Enkephalins, brain and immunity: Modulation of immune responses by methionine-enkephalin injected into the cerebral cavity. Int J Neurosci 1992;67:241–270.

    External Resources

  3. Radulović J, Mančev Z, Stanojević S, Vasiljević T, Kovačević-Jovanović V, Pešić G: Modulation of humoral immune response by central administration of leucine-enkephalin: Effects of μ, δ and κ opioid receptor antagonists. J Neuroimmunol 1996;65:155–161.
  4. Adamson WT, Windh RT, Blackford S, Kuhn CM: Ontogeny of mu- and kappa-opiate receptor control of the hypothalamo-pituitary-adrenal axis. Endocrinology 1991;129: 959–964.
  5. Carr DJ, Gebhardt BM, Paul D: Alpha adrenergic and mu-2 opioid receptors are involved in morphine-induced suppression of splenocyte natural killer activity. J Pharmacol Exp Ther 1993;264:1179–1186.
  6. Fecho F, Dykstra LA, Lysle DT: Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J Pharmacol Exp Ther 1993;265:1079–1087.
  7. Lopker A, Abood LG, Hoss W, Lionetti FJ: Stereoselective muscarinic, acetylcholine and opiate receptors in human phagocytic leukocytes. Biochem Pharmacol 1980;29:1361–1365.
  8. Ansiello CM, Roda, LG: Leu-enkephalin binding to cultured human T-lymphocytes. Cell Biol Int Rep 1984;8:353–362.

    External Resources

  9. Mathews PM, Froelich JC, Sibbit LW, Bankhurst DA: Enhancement of nature cytotoxicity by β-endorphin. J Immunol 1983;130:1658–1662.
  10. Carr DJ, DeCosta BR, Kim C-H, Jacobson AE: Opioid receptors on cells of the immune system: Evidence for δ- and κ-classes. J Endocrinol 1989;122:161–168.
  11. Radulescu RT, DeCosta BR, Jacobson AE, Rice KC, Blalock JE, Carr DJ: Biochemical and functional characterization of a μ-opioid receptor binding site on cells of the immune system. PNEI 1991;4:166–179.
  12. Gavériaux C, Peluso J, Simonin F, Laforet J, Kieffer B: Identification of κ- and δ-opioid transcripts in immune cells. FEBS Lett 1995;369:272–276.

    External Resources

  13. Hsueh C-M, Hiramoto RN, Ghanta VK: The central effect of methionine-enkephalin on NK cell activity. Brain Res 1992;578:142–148.
  14. Janković BD, Marić D: Enkephalins as regulators of inflammatory immune reactions; in Sharrer M, Smith ME, Stefano GB (eds): Neuropeptides and Immunoregulation. Berlin, Springer, 1994, pp 76–100.
  15. Janković BD, Marić D: Enkephalins modulate in vivo immune reactions through delta- and mu-opioid receptors. Ann NY Acad Sci 1988;540:691–693.
  16. Hucklebridge FH, Hudspith BN, Muhamed J, Lydyard PM, Brostoff J: Methionine-enkephalin stimulates in vitro proliferation of human peripheral lymphocytes via δ-opioid receptors. Brain Behav Immun 1989;3:183–189.
  17. Casellas AM, Guardiola H, Renaud FL: Inhibition by opioids of phagocytosis in peritoneal macrophages. Neuropeptides 1991;18:35–40.
  18. Fischer EG, Falke NE: Endogenous opioid peptides stimulate human phagocytes: Functional and binding studies. Adv Biosci 1987;66:373–379.
  19. Foris G, Medgyesi GA, Gyimesi E, Hauck M: Met-enkephalin induced alterations of macrophage functions. Mol Immunol 1984;21:747–750.
  20. Radulović J, Dimitrijević M, Laban O, Stanojević S, Vasiljević T, Kovačević-Jovanović V, Marković BM: Effect of met-enkephalin and opioid antagonists on rat macrophages. Peptides 1995;16:1209–1213.

    External Resources

  21. Corbett AD, Gillan MGC, Kosterlitz HW, McKnight AT, Paterson SJ, Robson LE: Selectivities of opioid peptide analogues as agonists and antagonists at the δ-receptor. Br J Pharmacol 1984;83:271–279.
  22. Radulović J, Miljević Č, Djergović D, Vujić V, Antić J, von Hörsten S, Janković BD: Opioid receptor-mediated suppression of humoral immune response in vivo and in vitro: involvement of κ opioid receptors. J Neuroimmunol 1995;57:55–57.

    External Resources

  23. Churchill L, Roques BP, Kalivas PW: Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both μ and δ opioid receptors. Psychopharmacology 1995;120:347–355.
  24. Leventhal L, Cole JL, Bodnar RJ: Reductions in locomotor activity following central opioid receptor subtype antagonists in rats. Physiol Behav 1996;60:833–836.

    External Resources

  25. Beluzzi JD, Gran N, Garasky V, Sarantakis D, Wise CD, Sein L: Analgesia induced in vivo by central administration of enkephalin in rat. Nature 1976;260:625–626.

    External Resources

  26. Dauge V, Samir A, Cupo A, Roques BP: Peripheral stimulation of CCK-B receptors by BC264 induces a hyperexploration, dependent on the partial derivative opioid system in the nucleus accumbens of rat. Neuropharmacology 1999;38:999–1007.

    External Resources

  27. Radulović J, Vujić V, Stanojević S, Vasiljević T, Kovačević-Jovanović V, Radulović M: Naturally occurring anti-peptide antibodies in the rat: Anti-Met-Enk antibodies; in Lukić ML, Čolić M, Mostarica-Stojković M, Čuperlović K (eds): Immunoregulation in Health and Disease. London, Academic Press, 1997, pp 197–203.
  28. Pick E, Mizel D: Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol 1981;46:211–226.
  29. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–275.
  30. Whittle BA: The use of changes in capillary permeability in mice to distinguish between narcotic analgesics. Br J Pharmacol 1964;22:246–253.
  31. Janković BD, Marić D: Enkephalins and immunity. I. In vivo suppression and potentiation of humoral immune response. Ann NY Acad Sci 1987;496:115–125.

    External Resources

  32. Stein C, Hassan AHS, Przewlocki R, Gramsch C, Peter K, Herz A: Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc Natl Acad Sci USA 1990;87:5935–5939.
  33. Schiable HG, Grubb BD: Afferent and spinal mechanisms of joint pain. Pain 1993;55:5–54.
  34. Blalock JE, Smith EM: Human leukocyte interferon: Structural and biological relatedness to adrenocorticotropin hormone and endorphins. Proc Natl Acad Sci USA 1980;77:5972–5974.
  35. Schäfer M, Carter L, Stein C: Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994;91:4219–4223.

    External Resources

  36. Van Epps DE, Saland L: β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J Immunol 1984;132:3046–3053.
  37. Kowalski J: Augmenting effect of opioids on nitrite production by stimulated murine macrophages. Neuropeptides 1998;32:287–291.
  38. Miller B: Delta opioid receptor expression is induced by concanavalin A in CD4+ T cells. J Immunol 1996;157:5324–5328.

    External Resources

  39. House RV, Thomas PT, Bhargava HN: A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 1996;17:75–81.
  40. Vujić V, Pešić G, Radulović J, Janković BD: Central modulation of humoral and cell mediated immune responses in the rat by endogenous enkephalin. Iugoslav Physiol Pharmacol Acta 1995;31:285–293.
  41. Hagi K, Uno K, Inaba K, Muramatsu S: Augmenting effects of opioid peptides on murine macrophage activation. J Neuroimmunol 1994;50:71–76.
  42. Roscetti G, Possenti R, Bassano E, Roda LG: Mechanisms of leu-enkephalin hydrolysis in human blood. Life Sci 1984;45:193–197.

    External Resources

  43. Pardrige WM, Mietus LJ: Enkephalin and blood brain barrier: studies of binding and degradation in isolated microvessels. Endocrinology 1981;109:1138–1145.

    External Resources

  44. Planas ME, Rodriguez L, Sanchez S, Pol O, Puig MM: Pharmacological evidence for the involvement of the endogenous opioid system in the response to local inflammation in the rat paw. Pain 1995;60:67–71.
  45. Michael-Titus A, Dourmap N, Costentin J, Schwartz JC: Role of delta-opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice. Neuropeptides 1990;15:89–100.

    External Resources

  46. Browne RG, Segal DS: Behavioral effects of opiates and opioid peptides. Biol Psychiatr 1980;15:77–86.
  47. Schulteis G, Martinez JL: Peripheral modulation of learning and memory: enkephalins as a model system. Psychopharmacology 1992;109:347–364.
  48. Klitenick MA, Wirtschafter D: Behavioral and neurochemical effects of opioids in the paramedian midbrain tegmentum including the median raphe nucleus and ventral tegmental area. J Pharmacol Exp Ther 1995;273:327–336.

    External Resources

  49. Pešić S, Pešić G, Mančev Z, Malobabić Z: Effect of met-enkephalin on rat visceral pain. Acta Med Mediane 1996;2:5–11.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50